Millennium: The Takeda Oncology Company and the WIN Consortium Become Partners in the Fight Against Cancer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company and the Worldwide Innovative Network (WIN) in personalized cancer medicine Consortium today announced the formation of a new partnership focused on bringing the latest advances in personalized cancer treatments to patients. The WIN Consortium is a global network of leading academic, industry, and patient advocacy organizations working to make personalized cancer care a reality for patients worldwide. It was founded on the recognition that greater success can be achieved through collaboration than any organization can achieve alone.